Moreover, in unpublished studies, we used co-transfection of rictor siRNA (to inhibit mTORC2) and siRNA targeting DEPTOR (an endogenous inhibitor of both mTORC1 and 2) to specifically activate mTORC1 in PHT cells. This evidence concerns the gene RICTOR and pulmonary hypertension, primary, 1.